Breaking News Instant updates and real-time market news.

RIGL

Rigel Pharmaceuticals

$2.50

-0.12 (-4.58%)

08:04
06/19/17
06/19
08:04
06/19/17
08:04

Rigel annouces FDA acceptance of NDA for Tavalisse in chronic ITP treatment

Rigel Pharmaceuticals announced the U.S. Food and Drug Administration has filed its New Drug Application for the use of Tavalisse in patients with chronic or persistent immune thrombocytopenia, or ITP. Rigel expects the action date for the FDA to complete its review will be April 17, 2018, under the Prescription Drug User Fee Act, or PDUFA. The FDA previously granted Orphan Drug designation to Tavalisse for the treatment of patients with ITP.

RIGL Rigel Pharmaceuticals
$2.50

-0.12 (-4.58%)

09/16/16
JEFF
09/16/16
NO CHANGE
Target $9
JEFF
Buy
Jefferies views Rigel restructuring positively, ups target to $9
Jefferies analyst Eun Yang views Rigel Pharmaceuticals' restructuring, which prioritizes fostamatinib commercialization while reducing research workforce, as a positive. The analyst notes the move will have no impact on the company's early programs. She raised her price target for Rigel shares to $9 from $8.50 and keeps a Buy rating on the name. Rigel closed yesterday up 4c to $3.45. The next major catalyst for the stock will be second Phase 3 data for fostamatinib in Immune Thrombocytopenic Purpura in October or November, Yang tells investors in a research note. She expects additional indications opportunities to drive "meaningful share price appreciation."
10/20/16
JPMS
10/20/16
NO CHANGE
JPMS
Overweight
Rigel has 20%-40% near-term downside, says JPMorgan
JPMorgan analyst Anupam Rama believes shares of Rigel Pharmaceuticals now have a regulatory uncertainty overhang after the company's second phase 3 trial of fostamatinib in immune thrombocytopenic missed statistical significance on its primary endpoint.There could ultimately be a registration path forward with combined phase 3 dataset, however, Rama tells investors in a research note. Nonetheless, the analyst sees the potential for 20%-40% share downside in the near-term. Rama has an Overweight rating on Rigel. The stock is down 34% to $2.11 in pre-market trading.
10/20/16
PIPR
10/20/16
NO CHANGE
PIPR
Overweight
Rigel Pharmaceuticals risk/reward remains favorable, says Piper Jaffray
With the stock down nearly 35% in pre-market trading, Piper Jaffray analyst Joshua Schimmer believes the risk/reward on shares of Rigel Pharmaceuticals remains favorable. The company on the conference call did an "excellent job" explaining the failed second Phase III results for fostamatinib in immune thrombocytopenic, Schimmer tells investors in a research note. He believes the drug has a "clear therapeutic benefit" and reiterates an Overweight rating on the stock with an $11 price target.
12/21/16
PIPR
12/21/16
NO CHANGE
PIPR
Piper lays out top BioPharma picks for 2017
Piper Jaffray analysts laid out their top BioPharma picks for 2017. Analyst Richard Purkiss favors Pfizer (PFE) and Eli Lilly (LLY) as his top large pharma picks. Analyst Joshua Schimmer calls Gilead (GILD) and Alexion (ALXN) his top large cap picks. Analyst David Amsellem names Horizon Pharma (HZNP) his top specialty pharma pick. Piper's other top Biopharma picks for 2017 include ACADIA (ACAD), Aimmune (AIMT), Akorn (AKRX), Alnylam (ALNY), Axovant Sciences (AXON), Cara Therapeutics (CARA), CoLucid Pharmaceuticals (CLCD), Eale Pharmaceuticals (EGRX), Exelixis (EXEL), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Neurocrine (NBIX), Nektar (NKTR), Otonomy (OTIC), Reata Pharmaceuticals (RETA), Rigel Pharmaceuticals (RIGL), Ignyta (RXDX), Theravance Biopharma (TBPH), Versartis (VSAR) and Voyager Therapeutics (VYGR). The analysts look for recent momentum in BioPharma to continue in 2017. They believe innovation and potentially repatriation should lead to increased merger activity.

TODAY'S FREE FLY STORIES

02:30
01/16/18
01/16
02:30
01/16/18
02:30
General news
FX Update: The dollar has settled above yesterday's trend lows »

FX Update: The dollar has…

01:45
01/16/18
01/16
01:45
01/16/18
01:45
General news
FX Action: USD-JPY has lifted to the upper 110.0s »

FX Action: USD-JPY has…

F

Ford

$13.23

0.07 (0.53%)

, FCAU

Fiat Chrysler

$23.39

-0.03 (-0.13%)

20:06
01/15/18
01/15
20:06
01/15/18
20:06
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

F

Ford

$13.23

0.07 (0.53%)

FCAU

Fiat Chrysler

$23.39

-0.03 (-0.13%)

SFTBY

SoftBank

$40.35

-0.705 (-1.72%)

GOOG

Alphabet

$1,122.26

16.74 (1.51%)

GOOGL

Alphabet Class A

$1,130.65

18.6 (1.67%)

TSLA

Tesla

$336.22

-1.73 (-0.51%)

BMWYY

BMW

$36.52

0.835 (2.34%)

TM

Toyota

$137.20

0.29 (0.21%)

GM

General Motors

$44.07

-0.12 (-0.27%)

VLKAY

Volkswagen

$44.34

1.065 (2.46%)

FB

Facebook

$179.37

-8.4 (-4.47%)

AMZN

Amazon.com

$1,305.20

28.52 (2.23%)

AAPL

Apple

$177.09

1.81 (1.03%)

NFLX

Netflix

$221.23

3.99 (1.84%)

VIVHY

Vivendi

$28.42

-1.035 (-3.51%)

BEN

Franklin Resources

$44.53

0.59 (1.34%)

PFE

Pfizer

$36.54

-0.02 (-0.05%)

AMGN

Amgen

$185.04

3.08 (1.69%)

ABBV

AbbVie

$100.34

1.07 (1.08%)

LLY

Eli Lilly

$86.98

0.59 (0.68%)

BMY

Bristol-Myers

$62.81

0.34 (0.54%)

JNJ

Johnson & Johnson

$145.76

0.97 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 25

    Jan

  • 26

    Jan

  • 30

    Jan

  • 30

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 03

    Feb

  • 05

    Feb

  • 06

    Feb

  • 06

    Feb

  • 07

    Feb

  • 08

    Feb

  • 16

    Feb

  • 05

    Mar

  • 18

    Mar

  • 25

    Mar

  • 30

    Apr

  • 17

    May

  • 28

    May

AAPL

Apple

$177.09

1.81 (1.03%)

19:29
01/15/18
01/15
19:29
01/15/18
19:29
Periodicals
China consumer group seeking answers from Apple on slowing iPhones, Reuters says »

A Chinese consumer group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

TWX

Time Warner

$92.05

0.16 (0.17%)

, CMCSA

Comcast

$42.44

-0.16 (-0.38%)

18:52
01/15/18
01/15
18:52
01/15/18
18:52
Hot Stocks
Box Office Battle: 'Jumanji' wins weekend again »

Sony's (SNE)…

TWX

Time Warner

$92.05

0.16 (0.17%)

CMCSA

Comcast

$42.44

-0.16 (-0.38%)

CMCSK

Comcast

SNE

Sony

$50.03

-0.25 (-0.50%)

FOX

21st Century Fox

$36.37

0.57 (1.59%)

FOXA

21st Century Fox

$36.73

0.53 (1.46%)

LGF.A

Lionsgate

$33.71

0.43 (1.29%)

DIS

Disney

$112.47

1.48 (1.33%)

VIAB

Viacom

$33.76

2.95 (9.57%)

VIA

Viacom

$39.10

3.45 (9.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 24

    Jan

  • 24

    Jan

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

FNSR

Finisar

$22.74

0.48 (2.16%)

18:41
01/15/18
01/15
18:41
01/15/18
18:41
Downgrade
Finisar rating change at Goldman Sachs »

Finisar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADTN

Adtran

18:41
01/15/18
01/15
18:41
01/15/18
18:41
Upgrade
Adtran rating change at Goldman Sachs »

Adtran upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

CIEN

Ciena

$21.94

0.06 (0.27%)

18:40
01/15/18
01/15
18:40
01/15/18
18:40
Upgrade
Ciena rating change at Goldman Sachs »

Ciena upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBY

SoftBank

$40.35

-0.705 (-1.72%)

18:36
01/15/18
01/15
18:36
01/15/18
18:36
Periodicals
Auto1 says no need for IPO following SoftBank investment, Reuters reports »

Auto1 said a $561M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$22.07

0.33 (1.52%)

18:32
01/15/18
01/15
18:32
01/15/18
18:32
Hot Stocks
FDA approves Teva's Trisenox injection for Acute Promyelocytic Leukemia »

Teva Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,122.26

16.74 (1.51%)

, GOOGL

Alphabet Class A

$1,130.65

18.6 (1.67%)

18:26
01/15/18
01/15
18:26
01/15/18
18:26
Periodicals
Google relaunching map service in China, Nikkei reports »

Google has relaunched its…

GOOG

Alphabet

$1,122.26

16.74 (1.51%)

GOOGL

Alphabet Class A

$1,130.65

18.6 (1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 18

    Mar

AAPL

Apple

$177.09

1.81 (1.03%)

, TCEHY

Tencent

$56.92

1.565 (2.83%)

18:24
01/15/18
01/15
18:24
01/15/18
18:24
Periodicals
Apple, Tencent reach deal to allow WeChat users dole out tips, WSJ says »

Apple (AAPL) and Tencent…

AAPL

Apple

$177.09

1.81 (1.03%)

TCEHY

Tencent

$56.92

1.565 (2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

RDS.A

Royal Dutch Shell

$70.88

1.04 (1.49%)

, RDS.B

Royal Dutch Shell

$72.70

0.97 (1.35%)

18:20
01/15/18
01/15
18:20
01/15/18
18:20
Periodicals
Shell acquires stake in solar energy company, Axios reports »

Royal Dutch Shell has…

RDS.A

Royal Dutch Shell

$70.88

1.04 (1.49%)

RDS.B

Royal Dutch Shell

$72.70

0.97 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$76.84

1.28 (1.69%)

18:17
01/15/18
01/15
18:17
01/15/18
18:17
Periodicals
Citi to raise pay for women, minorities, Reuters reports »

Citigroup will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

FCAU

Fiat Chrysler

$23.39

-0.03 (-0.13%)

18:10
01/15/18
01/15
18:10
01/15/18
18:10
Periodicals
Fiat Chrysler CEO rules out selling Jeep business, splitting up, WSJ reports »

Fiat Chrysler CEO Sergio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSRM

SSR Mining

$8.08

0.13 (1.64%)

18:06
01/15/18
01/15
18:06
01/15/18
18:06
Hot Stocks
SSR Mining reports production of over 370,000 gold equivalent ounces in 2017 »

SSR Mining said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$87.52

0.59 (0.68%)

17:57
01/15/18
01/15
17:57
01/15/18
17:57
Hot Stocks
Exxon Mobil encounters hydrocarbons onshore Papua New Guinea »

ExxonMobil announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEF

Central Fund of Canada Ltd

$13.68

0.23 (1.71%)

17:56
01/15/18
01/15
17:56
01/15/18
17:56
Hot Stocks
Central Fund of Canada Ltd, Sprott announce plan of arrangement closing date »

Central Fund of Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NJR

New Jersey Resources

$39.45

-0.1 (-0.25%)

17:52
01/15/18
01/15
17:52
01/15/18
17:52
Hot Stocks
Adelphia files application for certificate of public convenience and necessity »

Following the conclusion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 25

    Jun

NOK

Nokia

$4.87

0.05 (1.04%)

17:49
01/15/18
01/15
17:49
01/15/18
17:49
Hot Stocks
Nokia wins five-year managed services agreement to manage Optus' network »

Nokia and Optus have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSTR

MicroStrategy

$139.75

1.39 (1.00%)

, AMZN

Amazon.com

$1,305.20

28.52 (2.23%)

17:47
01/15/18
01/15
17:47
01/15/18
17:47
Hot Stocks
MicroStrategy announces rollout of MicroStrategy Partner Program »

MicroStrategy (MSTR)…

MSTR

MicroStrategy

$139.75

1.39 (1.00%)

AMZN

Amazon.com

$1,305.20

28.52 (2.23%)

MSFT

Microsoft

$89.60

1.52 (1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 31

    Jan

  • 07

    Feb

  • 18

    Mar

DAR

Darling Ingredients

$19.15

0.41 (2.19%)

17:37
01/15/18
01/15
17:37
01/15/18
17:37
Hot Stocks
Darling Ingredients announces new CFO, Chief Administrative Officer »

Darling Ingredients…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AON

Aon plc

$136.55

1.28 (0.95%)

17:34
01/15/18
01/15
17:34
01/15/18
17:34
Hot Stocks
Aon declares quarterly dividend of 36c per share »

Aon announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBR

KBR

$20.59

0.39 (1.93%)

17:32
01/15/18
01/15
17:32
01/15/18
17:32
Hot Stocks
KBR assures no disruptions on U.K. defense project »

KBR announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 25

    Jun

TRQ

Turquoise Hill

$3.57

0.06 (1.71%)

17:30
01/15/18
01/15
17:30
01/15/18
17:30
Hot Stocks
Turquoise Hill announces that Oyu Tolgoi received $155M Tax Act »

Turquoise Hill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.